Shares in partners Alkermes (ALKS) and Amylin Pharmaceuticals (AMLN) will resume trading at 4:15...

|About: Alkermes plc (ALKS)|By:, SA News Editor

Shares in partners Alkermes (ALKS) and Amylin Pharmaceuticals (AMLN) will resume trading at 4:15 p.m., after a halt this afternoon tied to the FDA's approval of their Bydureon weekly diabetes treatment. Updated 4:16 p.m.: ALKS +3.6% AH; AMLN +14.8% AH. Now for the tough part.